Inspire Veterinary Partners, Inc.
IVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.00 | -0.03 | 0.00 |
| FCF Yield | -38.53% | -182.26% | -8.27% | -6.77% |
| EV / EBITDA | -4.47 | -1.90 | -19.76 | -39.82 |
| Quality | ||||
| ROIC | -50.34% | -40.69% | -18.93% | -17.98% |
| Gross Margin | 19.84% | 21.31% | 25.88% | 32.53% |
| Cash Conversion Ratio | 0.70 | 0.26 | 0.54 | 0.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.05% | 87.02% | – | 1,365,942.53% |
| Free Cash Flow Growth | -143.64% | -48.30% | -22.18% | -41,937.54% |
| Safety | ||||
| Net Debt / EBITDA | -1.67 | -1.68 | -7.97 | -4.74 |
| Interest Coverage | -2.91 | -2.83 | -2.47 | -5.38 |
| Efficiency | ||||
| Inventory Turnover | 25.74 | 22.96 | 12.52 | 41.95 |
| Cash Conversion Cycle | -39.25 | -68.64 | -4.73 | 31.84 |